Position in RPRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,834,579
+$684,407 QoQ
Shares Held
86,224
-0.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#210
of 641 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Oxbow Advisors, LLC holds $8,176,129 across 2 Biotechnology names. RPRX ranks #1 (59.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
86,224 | $4,834,579 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,359 | $3,341,550 |
All Filings in RPRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,834,579 | 86,224 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,150,172 | 86,516 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,335,327 | 86,318 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,989,662 | 84,741 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||